Skip to main content

Find Clinical Trials

Home
Conditions
Metrorrhagia

Clinical trial condition

Metrorrhagia

Explore clinical trials studying Metrorrhagia. Study availability and eligibility vary by location and protocol.

114 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Metrorrhagia trial results

Completed

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

NCT01647360

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: Site reference ID/Investigator# 79836 Islamabad, Federal Capital, Pakistan

Site Reference ID/Investigator# 77674 Karachi, Sindh, Pakistan

Site Reference ID/Investigator# 77675 Karachi, Sindh, Pakistan

Site reference ID/Investigator# 77676 Karachi, Sindh, Pakistan

View all 20 locations

View Trial Details

Completed

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

NCT01436903

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: Landesklinikum Thermenregion Neunkirchen Neunkirchen, Lower Austria, Austria

View Trial Details

Completed

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

NCT01026805

Conditions: Abnormal Uterine Bleeding, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Not specified

View Trial Details

Completed

Endometrial Ablation With Non-hysteroscopic Methods

NCT01173965

Conditions: Dysfunctional Uterine Bleeding, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: First Dept. Of ObGyn, Medical School Aristotle University of Thessaloniki, Papageorgiou Hospital Thessaloniki, Greece

First Dept. of ObGyn, Medical School, Aristotle University of Thessaloniki, Papageorgiou Hospital Thessaloniki, Greece

View Trial Details

Completed

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

NCT01436513

Conditions: Adnexal Diseases, Endocrine System Diseases, Female Urogenital Diseases, +16 more
Locations: Pfizer Investigational Site Shinjyuku-ku, Tokyo, Japan

View Trial Details

Completed

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals

NCT00700128

Conditions: Bleeding, Brain Diseases, Central Nervous System Diseases, +21 more
Locations: Scott & White Memorial Hospital Temple, Texas, United States

View Trial Details

Completed

An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

NCT00320580

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

NCT00344383

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

NCT00475553

Conditions: Breakthrough Bleeding, Breakthrough Spotting, Female Urogenital Diseases, +15 more
Locations: Scott & White Hospital and Clinic Temple, Texas, United States

View Trial Details

Completed

Genistein and Endometrial Hyperplasia

NCT00453960

Conditions: Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Menopause Centre, Department of Gynecology and Obstetrics, Policlinico Universitario "G.Martino" Messina, Italy

View Trial Details